Clinical trials
Terminated Melanoma trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 3 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 5 |
| Merck Sharp & Dohme LLC | 2 |
| Amgen | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| CytomX Therapeutics | 1 |
| Day One Biopharmaceuticals, Inc. | 1 |
| Eisai Inc. | 1 |
| Eli Lilly and Company | 1 |
| GlaxoSmithKline | 1 |
| Incyte Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Melanoma | 22 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Carcinoma, Renal Cell | 5 |
| Squamous Cell Carcinoma of Head and Neck | 5 |
| Colorectal Neoplasms | 3 |
| Esophageal Squamous Cell Carcinoma | 3 |
| Neoplasms | 3 |
| Carcinoma, Hepatocellular | 2 |
| Lymphoma | 2 |
| Neoplasm Metastasis | 2 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.